THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 50 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | – | 63 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 63 | -94.9% | 0.00% | – |
| Q2 2016 | $1,000 | – | 1,239 | -84.1% | 0.00% | – |
| Q1 2016 | $0 | – | 7,800 | -93.2% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 114,763 | +111.3% | 0.00% | – |
| Q3 2015 | $217,000 | +228.8% | 54,303 | +230.3% | 0.00% | – |
| Q2 2015 | $66,000 | +4.8% | 16,440 | +4.6% | 0.00% | – |
| Q1 2015 | $63,000 | -30.8% | 15,721 | -48.4% | 0.00% | – |
| Q4 2014 | $91,000 | -52.1% | 30,482 | -51.5% | 0.00% | – |
| Q3 2014 | $190,000 | -15.6% | 62,806 | -15.6% | 0.00% | – |
| Q2 2014 | $225,000 | -77.3% | 74,456 | -70.0% | 0.00% | -100.0% |
| Q1 2014 | $991,000 | +725.8% | 247,796 | +727.1% | 0.00% | – |
| Q4 2013 | $120,000 | +26.3% | 29,958 | +26.1% | 0.00% | – |
| Q3 2013 | $95,000 | -35.8% | 23,765 | -15.6% | 0.00% | – |
| Q2 2013 | $148,000 | – | 28,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 393,000 | $1,556,000 | 1.48% |
| FORTALEZA ASSET MANAGEMENT INC/ | 98,125 | $389,000 | 0.18% |
| Rhenman & Partners Asset Management AB | 121,537 | $481,000 | 0.14% |
| Baker Brothers Advisors | 1,826,358 | $7,232,000 | 0.09% |
| Rotella Capital Management, Inc. | 21,600 | $86,000 | 0.07% |
| SSI INVESTMENT MANAGEMENT LLC | 117,640 | $466,000 | 0.04% |
| FEDERATED HERMES, INC. | 2,391,400 | $9,470,000 | 0.03% |
| TFS CAPITAL LLC | 96,659 | $383,000 | 0.03% |
| SMITH ASSET MANAGEMENT GROUP LP | 191,038 | $757,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 28,000 | $111,000 | 0.02% |